Your browser doesn't support javascript.
loading
Anti-CD22 Calicheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azacitidine in the Treatment of Mixed-Phenotype Acute Leukemia: A Case Report
Li, Kongfei; Wang, Yuxiao; Pei, Renzhi; Lu, Ying; Cao, Junjie; Zhuang, Xianxu; Lian, Jiaying; Zhang, Bibo.
Affiliation
  • Li K; The Affiliated People's Hospital of Ningbo University, Department of Hematology, Ningbo, China
  • Wang Y; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, China
  • Pei R; The Affiliated People's Hospital of Ningbo University, Department of Hematology, Ningbo, China
  • Lu Y; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, China
  • Cao J; The Affiliated People's Hospital of Ningbo University, Department of Hematology, Ningbo, China
  • Zhuang X; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, China
  • Lian J; The Affiliated People's Hospital of Ningbo University, Department of Hematology, Ningbo, China
  • Zhang B; Ningbo University, Institute of Hematology, Department of Hematology, Ningbo, China
Turk J Haematol ; 41(3): 202-204, 2024 08 28.
Article in En | MEDLINE | ID: mdl-39078014

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Azacitidine / Antineoplastic Combined Chemotherapy Protocols / Bridged Bicyclo Compounds, Heterocyclic / Inotuzumab Ozogamicin Limits: Humans / Male / Middle aged Language: En Journal: Turk J Haematol Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Azacitidine / Antineoplastic Combined Chemotherapy Protocols / Bridged Bicyclo Compounds, Heterocyclic / Inotuzumab Ozogamicin Limits: Humans / Male / Middle aged Language: En Journal: Turk J Haematol Year: 2024 Document type: Article Affiliation country: Country of publication: